Literature DB >> 32573143

[Research progress on the biological regulatory function of lysophosphatidic acid in bone tissue cells].

Xiang-Nan Wu1, Yuan-Yuan Ma2, Zhi-Chao Hao2, Hang Wang3.   

Abstract

Lysophosphatidic acid (LPA) is a small phospholipid that is present in all eukaryotic tissues and blood plasma. As an extracellular signaling molecule, LPA mediates many cellular functions by binding to six known G protein-coupled receptors and activating their downstream signaling pathways. These functions indicate that LPA may play important roles in many biological processes that include organismal development, wound healing, and carcinogenesis. Recently, many studies have found that LPA has various biological effects in different kinds of bone cells. These findings suggest that LPA is a potent regulator of bone development and remodeling and holds promising application potential in bone tissue engineering. Here, we review the recent progress on the biological regulatory function of LPA in bone tissue cells.

Entities:  

Keywords:  bone tissue engineering; lysophosphatidic acid; osteoblast; osteoclast; osteocyte

Mesh:

Substances:

Year:  2020        PMID: 32573143      PMCID: PMC7296378          DOI: 10.7518/hxkq.2020.03.017

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  52 in total

Review 1.  Lysophosphatidic acid signalling in development.

Authors:  Xiaoyan Sheng; Yun C Yung; Allison Chen; Jerold Chun
Journal:  Development       Date:  2015-04-15       Impact factor: 6.868

2.  Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA6.

Authors:  Reiya Taniguchi; Asuka Inoue; Misa Sayama; Akiharu Uwamizu; Keitaro Yamashita; Kunio Hirata; Masahito Yoshida; Yoshiki Tanaka; Hideaki E Kato; Yoshiko Nakada-Nakura; Yuko Otani; Tomohiro Nishizawa; Takayuki Doi; Tomohiko Ohwada; Ryuichiro Ishitani; Junken Aoki; Osamu Nureki
Journal:  Nature       Date:  2017-08-09       Impact factor: 49.962

3.  Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.

Authors:  Keisuke Yanagida; Kayo Masago; Hiroki Nakanishi; Yasuyuki Kihara; Fumie Hamano; Yoko Tajima; Ryo Taguchi; Takao Shimizu; Satoshi Ishii
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

4.  Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.

Authors:  Marion David; Irma Machuca-Gayet; Junichi Kikuta; Penelope Ottewell; Fuka Mima; Raphael Leblanc; Edith Bonnelye; Johnny Ribeiro; Ingunn Holen; Rùben Lopez Vales; Pierre Jurdic; Jerold Chun; Philippe Clézardin; Masaru Ishii; Olivier Peyruchaud
Journal:  J Biol Chem       Date:  2014-01-15       Impact factor: 5.157

5.  Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells.

Authors:  Lisa M Masiello; Joseph S Fotos; Deni S Galileo; Norman J Karin
Journal:  Bone       Date:  2006-02-17       Impact factor: 4.398

6.  P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.

Authors:  Mike Lee; Sungwon Choi; Gunnel Halldén; Sek Jin Yo; Denise Schichnes; Gregory W Aponte
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-08-13       Impact factor: 4.052

7.  Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.

Authors:  Jinghai Chen; Anwar R Baydoun; Ruixia Xu; Linzi Deng; Xuebin Liu; Weiquan Zhu; Linhui Shi; Xiangfeng Cong; Shengshou Hu; Xi Chen
Journal:  Stem Cells       Date:  2007-10-11       Impact factor: 6.277

8.  Hypoxia regulates angeogenic-osteogenic coupling process via up-regulating IL-6 and IL-8 in human osteoblastic cells through hypoxia-inducible factor-1α pathway.

Authors:  Xiulong Niu; Yumeng Chen; Lin Qi; Guoqing Liang; Yue Wang; Lipeng Zhang; Ye Qu; Wenliang Wang
Journal:  Cytokine       Date:  2018-06-19       Impact factor: 3.861

Review 9.  Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.

Authors:  Silvia Anahi Valdés-Rives; Aliesha González-Arenas
Journal:  Mediators Inflamm       Date:  2017-12-21       Impact factor: 4.711

10.  Pigment Epithelium-Derived Factor (PEDF) Protects Osteoblastic Cell Line from Glucocorticoid-Induced Apoptosis via PEDF-R.

Authors:  Shengcheng Yao; Yingnan Zhang; Xiaoyu Wang; Fengchao Zhao; Maji Sun; Xin Zheng; Hongyan Dong; Kaijin Guo
Journal:  Int J Mol Sci       Date:  2016-05-13       Impact factor: 5.923

View more
  1 in total

1.  Metabolic Profiling Analysis of the Effect and Mechanism of Gushiling Capsule in Rabbits With Glucocorticoid-Induced Osteonecrosis of the Femoral Head.

Authors:  Runhong Mei; Dan Chen; Duming Zhong; Guoyong Li; Shaobai Lin; Guangquan Zhang; Kaiyun Chen; Xuefeng Yu
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.